Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$829K Buy
+2,289
New +$784K 0.2% 108
2026
Q1
Sell
-1,851
Closed -$606K 253
2025
Q4
$606K Buy
+1,851
New +$587K 0.15% 137
2025
Q3
Sell
-3
Closed -$1K 251
2025
Q2
$1K Hold
3
﹤0.01% 243
2025
Q1
$1K Sell
3
-710
-100% -$210K ﹤0.01% 238
2024
Q4
$186K Sell
713
-558
-44% -$166K 0.06% 160
2024
Q3
$410K Sell
1,271
-168
-12% -$55K 0.07% 133
2024
Q2
$450K Sell
1,439
-2,087
-59% -$613K 0.07% 118
2024
Q1
$1M Hold
3,526
0.09% 97
2023
Q4
$1.02M Sell
3,526
-121
-3% -$33K 0.09% 83
2023
Q3
$980K Buy
3,647
+15
+0.4% +$3.74K 0.08% 96
2023
Q2
$806K Sell
3,632
-665
-15% -$154K 0.06% 121
2023
Q1
$1.04M Buy
4,297
+1,465
+52% +$360K 0.07% 109
2022
Q4
$744K Hold
2,832
0.05% 122
2022
Q3
$638K Hold
2,832
0.04% 134
2022
Q2
$689K Buy
2,832
+167
+6% +$40.9K 0.04% 150
2022
Q1
$644K Buy
2,665
+824
+45% +$189K 0.03% 164
2021
Q4
$414K Hold
1,841
0.02% 154
2021
Q3
$391K Hold
1,841
0.02% 156
2021
Q2
$449K Sell
1,841
-164
-8% -$40.3K 0.02% 154
2021
Q1
$499K Hold
2,005
0.02% 141
2020
Q4
$461K Hold
2,005
0.02% 147
2020
Q3
$510K Buy
+2,005
New +$497K 0.03% 137

Other funds holding AMGN

TOBAM's AMGN Position: Q2 2026 in Review

TOBAM opened a new position in Amgen (AMGN) in Q2 2026: 2,289 shares worth $829K. The stake represents 0.2% of the portfolio and ranks #108 among its holdings. This is a return to the name: TOBAM previously reported a position in AMGN as recently as Q4 2025.

TOBAM first reported a position in AMGN in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.04M in Q1 2023. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TOBAM held 2,289 shares of Amgen worth $829K as of Q2 2026.
  • Amgen was a new TOBAM position in Q2 2026.
  • Amgen made up 0.2% of TOBAM's portfolio in Q2 2026, its #108 holding.
  • TOBAM first reported a position in Amgen in Q3 2020 and has held it in 22 quarters since.
  • TOBAM's Amgen position peaked at $1.04M in Q1 2023.
  • 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.